BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 7715380)

  • 1. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
    McGuirt WF; Williams DW; Keyes JW; Greven KM; Watson NE; Geisinger KR; Cappellari JO
    Laryngoscope; 1995 Apr; 105(4 Pt 1):373-5. PubMed ID: 7715380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
    Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
    Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
    Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
    Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(18)F]-FDG PET/CT imaging for detection of nodal metastases in patients with squamous cell carcinoma of the pharynx and larynx: comparison with CT.
    Suenaga Y; Kitajima K; Kanda T; Otsuki N; Nibu K; Sasaki R; Itoh T; Sugimura K
    Jpn J Radiol; 2016 Mar; 34(3):203-10. PubMed ID: 26670594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma.
    Jeong HS; Baek CH; Son YI; Ki Chung M; Kyung Lee D; Young Choi J; Kim BT; Kim HJ
    Head Neck; 2007 Mar; 29(3):203-10. PubMed ID: 17111430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
    Stokkel MP; ten Broek FW; Hordijk GJ; Koole R; van Rijk PP
    Ann Surg; 2000 Feb; 231(2):229-34. PubMed ID: 10674615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma.
    Piao Y; Bold B; Tayier A; Ishida R; Omura K; Okada N; Shibuya H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Dec; 108(6):933-8. PubMed ID: 19846326
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
    Myers LL; Wax MK
    J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
    Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma.
    Kim SY; Kim JS; Doo H; Lee H; Lee JH; Cho KJ; Choi SH; Nam SY; Roh JL
    Oral Oncol; 2011 May; 47(5):376-80. PubMed ID: 21470899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promise FDG in diagnosis and surveillance of head and neck cancer.
    Mancuso AA; Drane WE; Mukherji SK
    Cancer; 1994 Aug; 74(4):1193-5. PubMed ID: 8055436
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography in the evaluation of the N0 neck.
    Myers LL; Wax MK; Nabi H; Simpson GT; Lamonica D
    Laryngoscope; 1998 Feb; 108(2):232-6. PubMed ID: 9473074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
    Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
    Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of positron emission tomography in the evaluation of the N-positive neck.
    Wax MK; Myers LL; Gona JM; Husain SS; Nabi HA
    Otolaryngol Head Neck Surg; 2003 Sep; 129(3):163-7. PubMed ID: 12958562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Computed tomography of cervical lymph node metastases in malignant tumors of the head and neck region].
    Bähren W; Haase S; Lenz M; Ranzinger G; Wierschin W
    Rofo; 1983 Sep; 139(3):281-4. PubMed ID: 6411547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predictive ability of the CT to evaluate cervical lymph nodes in head and neck tumours].
    Iñarra Unzurrunzaga E; Gorriño Angulo M; Vidales Arechaga L; Aguirre Larracoechea U; Iriondo Bedialauneta JR
    Acta Otorrinolaringol Esp; 2011; 62(6):443-7. PubMed ID: 21958675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.
    Brkovich VS; Miller FR; Karnad AB; Hussey DH; McGuff HS; Otto RA
    Laryngoscope; 2006 Jun; 116(6):855-8. PubMed ID: 16735902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.